Aaron Robinson, PhD

Aaron Robinson, PhD has a diverse work experience in the field of mass spectrometry and proteomics. Aaron currently works at Amunix Pharmaceuticals as a Mass Spectrometry Senior Scientist, specializing in quantitative mass spectrometry-based discovery proteomics screens. Their responsibilities include experimental design, mass spectrometry operations, and data analysis. Aaron is highly skilled in various mass spectrometry techniques and instrumentation.

Prior to their current role, Aaron held positions at Stanford University School of Medicine and Cedars-Sinai as a Postdoctoral Researcher. At Stanford, they focused on multi-omics integration of human disease, method development, and data analysis of mass spectrometry-based quantitative proteomics and systems biology. At Cedars-Sinai, they developed a novel technique to detect and quantify protein methylation using mass spectrometry. Aaron also worked on a novel polymer therapy for blood acidosis at Tricida, Inc.

Aaron has also gained experience as a Research Specialist/Laboratory Manager at the University of California, San Francisco, where they managed laboratory operations and logistics. Aaron previously worked as a Research Assistant at the University of California, Davis, studying the interaction between tomatoes and the fungal pathogen botrytis.

Overall, Aaron Robinson, PhD has demonstrated expertise in mass spectrometry, proteomics, and lab management throughout their career.

Aaron Robinson, PhD obtained their Doctor of Philosophy (Ph.D.) in Biomedical Science and Translational Medicine from Cedars-Sinai between 2014 and 2019. Prior to that, they completed their Bachelor of Science degree at the University of California, Davis from 2005 to 2009, with a major in Animal Biotechnology and a minor in Technology Management. Aaron Robinson's secondary education took place at Los Altos High School, from 2001 to 2005, although the information regarding a specific degree or field of study is not provided.